Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage III Breast Cancer AJCC v8;   Early Stage Triple-Negative Breast Carcinoma Interventions:   Biological: Pembrolizumab;   Other: Patient Observation;   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials